started · updated
BPOM and Bio Farma discuss AI for polio vaccine quality testing
The Indonesian Food and Drug Authority (BPOM) and PT Bio Farma are discussing the implementation of artificial intelligence (AI) to assist in the quality testing of polio vaccines. The collaboration focuses on using AI to analyze histopathology images during neurovirulence testing, a process that currently relies on manual reading.
Bio Farma Director Iin Susanti stated that the technology is expected to make the testing process more than twice as fast while increasing consistency and accuracy. The use of AI aims to reduce human error and fatigue caused by analyzing hundreds or thousands of samples. Bio Farma intends to ensure the system is robust and reliable in detecting virulent viruses before full implementation, which is targeted for approximately one year from now.
BPOM Head Taruna Ikrar emphasized that technological advancements must be accompanied by regulatory certainty to guarantee the safety, quality, and efficacy of products. He noted that AI is increasingly being integrated into various stages of vaccine production, including protein structure arrangement, synthesis, distribution, and testing.
Entities
BPOM · Bandung · Bio Farma · Iin Susanti · Taruna Ikrar